Come up with a name for your new list and we'll add to it:
WavoDyne Therapeutics raised a round of funding on August 29, 2014. Investors include
National Institutes of Health.
WavoDyne Therapeutics was formed for the purpose of commercializing a group of novel small molecule therapeutics which have displayed exceptional potency in preclinical models for the treatment of mem…